Treating Hyperkalemia: Avoid Additional Harm When Using ...
available insulin products (e.g., humul%, novol%), Kayexalate , and polystyrene. One hundred ninety-eight events met the inclusion criteria and were included in the final analysis.
Download Treating Hyperkalemia: Avoid Additional Harm When Using ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Opioid Knowledge Self-Assessment
patientsafety.pa.govOpioid Knowledge Self-Assessment Healthcare facilities can use this assessment for practitioners who prescribe, dispense, and/or administer opioid products ...
Letter to the Editor: Preventing Air Embolism with PICC ...
patientsafety.pa.govletter to the editor: preventing air embolism with picc line removal I read with interest your article “Reducing Risk of Air Embolism Associated with Central Venous Access Devices” in the Pennsyl-
Strategic Plan 2017-2020 - Patient Safety Authority
patientsafety.pa.govStrategic Plan During 2016, the Pennsylvania Patient Safety Authority Board of Directors and staff engaged in a third strate- ... Strategic Plan 2017–2020 VISION Safe healthcare for all patients MISSION Improve the quality of healthcare in Pennsylvania by collecting and
PATIENT SAFETY: COLOR BANDING Standardization and ...
patientsafety.pa.govColor-banding policy will need to be reviewed and approved. Hospitals need to review their respective forms for need of modifications (pt. ed, assessments, etc.) ... • Color Code – Intent of Specific Colors • Authority for Application of band • Process for Band Confirmation • Inter-Dept./Agency Communication
Confirming Feeding Tube Placement: Old Habits Die Hard
patientsafety.pa.govMore Reliable Methods to Verify Feeding Tube Placement Radiographic Confirmation of Nasogastric Tube Placement The gold standard for nasogastric feeding tube placement is radiographic confirmation with a chest x-ray. pretations by nonradiologists: The gold standard for nasoenteric feeding tube placement is radiographic confir-
The Beers Criteria: Screening for Potentially ...
patientsafety.pa.govhepatic clearance of many drugs, such as diazepam, amitriptyline, and chlordiazepoxide, carried out by the cytochrome P-450 system often diminishes with age. Overall, the clearance of drugs metabolized by the liver is typically decreased 30 to 40% in the elderly. Renal size and renal blood flow also decrease signifi-cantly with age.
Safety in Using Promethazine (Phenergan)
patientsafety.pa.gov©2007 Pennsylvania Patient Safety Authority Page 1 Produced by ECRI Institute & ISMP under contract to the Patient Safety Authority Patient Safety Advisory F irst approved by the U.S. Food and Drug Ad-ministration (FDA) in 1951, promethazine (Phenergan) is a medication in common use today. However, despite its familiarity, its use is not with-
PATIENT SAFETY AUTHORITY AND DEPARTMENT OF HEALTH
patientsafety.pa.gov12. A mid-procedure change in the plan of care in response to new information discovered during the procedure does not constitute an injury. 13. Additional healthcare services: a. Healthcare services provided to prevent an injury from occurring are excluded from this term for the purpose of Serious Event determinations. b.
Brochure Medical Records - Pennsylvania Patient Safety ...
patientsafety.pa.govrecord. In the future, when medi-cal records are requested by other providers, your provider must include his denial of your request to amend the medical record as well a copy of your statement of disagreement. It should not take more than 90 days to amend your medical records. If the request is accepted,
Retained Surgical Items: Events and Guidelines Revisited
patientsafety.pa.govand the Association of periOperative Registered Nurses published guidance for preventing RSIs, including minimizing distractions and participating in team-work training. The Joint Commission speaks to the role of weak or absent organizational leadership as reasons for the continuance of RSIs. (Pa Patient Saf Advis 2017 Mar;14[1]:27-35.)
Related documents
All of the following medications are gluten free unless ...
glutenfreedrugs.comKayexalate Keflex Kemadrin Keppra (all strengths) Ketek Ketoprofen XR (Andrx) Kirkman (all products are GF) Klor-Con Lacrisert Lactaid Fast Act Chewables- No gluten or any carbohydrates Lactaid Fast Act Caplets- No gluten or any carbohydrates Lamictal Lamisil Lamprene Lanoxin Lasix Leflunomide (Apotex, Sandoz) Lescol / XL Lessina-28 Leucovorin
MAINTENANCE FLUID REQUIREMENTS RESUSCITATION …
anesthesia.ucsf.eduKayexalate 1-2 g/kg PO/PR ENDOCARDITIS PROPHYLAXIS GUIDELINES AHA 2007 At risk conditions 1. Presence of prosthetic valve or prosthetic material used for cardiac valve repair 2. A history of endocarditis 3. A heart transplant with abnormal heart valve function 4. Congenital heart disease: Uncorrected or palliated cyanotic CHD, completely repaired
Management of severe hyperkalemia - EMCrit
emcrit.org(Kayexalate, Kionex) 15–30 g in 15–30 mL (70% sorbitol orally) 2 hrs 4–6 hrs Variable efficacy intestinal necrosis Hemodialysis Immediate 3 hrs Arrhythmias (?) IV, intravenously. Crit Care Med 2008 Vol. 36, No. 12 3247. agent is the gluconate salt, since it is less
Lab Values: Interpreting Chemistry and Hematology for ...
lms.rn.comMar 30, 2012 · • Kayexalate: This is a cation-exchange resi n, Na+ based (An ion-exchange resin that has the ability to exchange positive ions in the stationary phase with positive ions in solution) • Calcium administration: Used to decrease the antagonistic effect …
Kayexalate (Sodium Polystyrene Sulfonate)
products.sanofi.caKAYEXALATE Prescribing Information Page 2 of 12 DESCRIPTION KAYEXALATE (sodium polystyrene sulfonate) is a cream or light brown fine powder of sodium polystyrene sulfonate. KAYEXALATE is a cation-exchange resin prepared in the sodium phase, with an in vivo exchange capacity of approximately 1 mmol (in vitro
Best Practices in Managing Table 3. 6 HYPERKALEMIA
www.kidney.orgTREATMENT OF HYPERKALEMIA IN CKD. REFERENCES . Table 3. 30 East 33rd Street. New York, NY 10016 800.622.9010. www.kidney.org. This publication has been sponsored and developed in collaboration with Relypsa, Inc.
Hyperkaliémie
www.srlf.orgRésines échangeuses d’ions KAYEXALATE® PO 15-30g / 4-6H, ou en lavement 50-100 g gardé 30-60 min Facteurs pronostiques Urgence métabolique absolue si : K+ > 7 mmol/L et/ou signes ECG. Indication Hémodialyse en urgence. En attente de dialyse = sels de calcium + 1 traitement hypokalièmiant par transfert du K+ en intracellulaire.